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Abstract
Purpose: Research has revealed a well-established relationship of depressive symptoms and
hopelessness with a variety of physical illnesses that are associated with a dysfunction of the
hypothalamic-pituitary-adrenal-axis. The purpose of this study was to test if depressive
symptoms mediate the relationship between hopelessness and cortisol, a measure of the
hypothalamic-pituitary-adrenal-axis. Methods: Hopelessness, depressive symptoms, and diurnal
cortisol rhythm were measured in 257 adults (128 women and 129 men; age range: 20-74 years)
in this cross-sectional study. To test the hypothesis, two linear regression analyses and
asymmetrical confidence intervals around the regression weights were conducted. A second set
of analyses was calculated to be able to exclude the possibility of hopelessness as a mediator
between depressive symptoms and cortisol. Results: As predicted, after adjusting for age,
gender, awakening time, medication use, more hopelessness predicted more depressive
symptoms and more depressive symptoms predicted a flatter diurnal cortisol rhythm. The 95%
confidence intervals revealed that the indirect relationship between hopelessness and diurnal
cortisol rhythm was significant. The analyses with hopelessness as a potential mediator revealed
that hopelessness does not mediate the association between depressive symptoms and cortisol.
Conclusions: While the relationship between hopelessness and cortisol was mediated by
depressive symptoms in this cross-sectional study, many other risk factors of depression have not
been examined. Thus, future longitudinal studies should examine the relationships between
those risk factors of depression and the hypothalamic-pituitary-adrenal-axis.

Keywords: population-based; cross-sectional study; mediation model; hopelessness; depressive
symptoms; diurnal cortisol rhythm
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Presently, psychosocial factors in general, and depressive symptoms in particular, are
prospectively associated with incidents of both cancer and cardiovascular disease (CVD) [for
meta-analyses see 1 and 2; 3; 4, respectively]. In the field of clinical psychology, two prominent
models explaining the development of depressive symptoms based on cognitive risk factors have
been well-supported by decades of research: Beck’s cognitive theory [5] and the hopelessness
model [6]. One crucial risk factor for the development and maintenance of depressive symptoms
in both models is hopelessness. Hopelessness is a negative view of the future, or in other words,
hopeless persons make long-range projections, anticipating that current difficulties or suffering
will continue indefinitely [5, 6]. Hopelessness is important for the purpose of this study, as
empirical studies have also found it to be associated with cancer and CVD incidents. For
example, a 6-year longitudinal study with middle aged men without a history of CVD or other
serious illness at baseline revealed that hopelessness is associated with incidence rates of
myocardial infarction (MI) and cancer, even after controlling for age and depressive symptoms
[7]. This raises the question of whether hopelessness predicts depessive symptoms which is
associated with physical illness. In other words, it is possible that depressive symptoms mediate
the association between hopelessness and physical illness.
While we are not aware of any study testing if depressive symptoms mediate the
associations between hopelessness and physical illness, one cross-sectional study [8] with
healthy women found that hopelessness significantly predicts mean and maximum carotid artery
intima-media thickening (IMT) while depressive symptoms predicted IMT only marginally, both
while controlling for age, race/ethnicity (European-American & African-American), income,
BMI, SBP, and smoking. After entering hopelessness and depressive symptoms in the same
model and continuing to control for all other variables, hopelessness but not depressive

Running head: Depressive Symptoms, Hopelessness, and Cortisol

4

symptoms remained a predictor of IMT. In addition, another study tested whether hopelessness
and depressive symptoms were independently associated with instances of myocardial
infarctions [9]. This 18-year longitudinal study with men without previous MI revealed that
hopelessness and depressive symptoms predicted MI incidents when not controlling for each
other. However, when controlling for hopelessness, depressive symptoms no longer significantly
influenced the men’s risk of an MI. Further, hopelessness continued to predict MI incidents even
after controlling for depressive symptoms. Thus, while this particular study did not identify
whether depressive symptoms mediated the association between hopelessness and MI, results
suggested that hopelessness and depressive symptoms are not independently associated with this
particular health condition.
A possible pathway for the associations between depressive symptoms and hopelessness
with cancer and CVD is the psychobiological response to stress. The term stress is ambiguous
and is often used to describe a variety of constructs. However, in this instance, stress is
understood as one or more events that are seen by the individual which experiences the event(s)
as threatening and therefore trigger(s) a psychobiological response. A central component of this
stress response is the (hypothalamic-pituitary-adrenal-axis) HPA-axis involving the release of the
corticosteroid cortisol [10]. The release of cortisol is an adaptive and necessary response for
survival, mobilizing resources to meet new demands [11]; however, if not in balance, the stress
response may lead to an increased risk of disease through the metabolic effects of sustained high
cortisol levels, the immunosuppressive effects of cortisol, or effects resulting from the inability
to respond to new demands (or a combination of these effects). Thus, both the capacity to
respond to a stressful event and subsequently relax after the event is important [12]. To assess
this capacity, methods have been developed to test stress response. One measure of stress
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response is the decline of cortisol from morning to evening (i.e., diurnal cortisol rhythm).
Similar to chronic stress [e.g., 13; 14] and other psychosocial variables such as bereavement [15]
and loneliness [16], both depressive symptoms and hopelessness have been related to smaller
differences between morning and evening values [i.e., flatter rhythm; e.g., 17; 18]. However, as
far as we know, no study has tested whether hopelessness is a risk factor of both depressive
symptoms and flatter cortisol rhythm and if depressive symptoms mediate the association
between hopelessness and diurnal cortisol rhythm.
Based on the above presented theoretical considerations and previously published data
finding significant and marginally significant associations of depressive symptoms and
hopelessness with flatter diurnal cortisol rhythms, respectively [17; 18], it will be expected that
depressive symptoms mediate the association between hopelessness and diurnal cortisol rhythm.
However, it can not be excluded that hopelessness mediates the association between depressive
symptoms and cortisol rhythm. Thus, an alternative model reflecting that depressive symptoms
mediate the association between hopelessness and diurnal cortisol rhythm will be tested as well.
Method
Participants
This study utilized data obtained from a public health survey that was administered in
two phases. In the first phase of data collection, participants consisted of a random sample of
10,000 residents of the county of Östergötland in Sweden, with a response rate of 61%. The
second phase of data collection invited a random sample of 400 participants (200 women and
200 men) from the first phase of data collection to participate in a study examining the current
constructs of interest. The response rate was 64.5% and included 257 participants from the
greater population. Relevant demographic information was collected from participants,
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including age (mean = 48.12, SD = 9.64), gender (128 women and 129 men), awakening time
(mean = 6:08 a.m., SD = 1.05 hours), medication (153 do not take medication regularly and 95
take medication regularly), education (128 basic school and two years of upper secondary and
119 three years of upper secondary and/or university studies), type of labor (66 blue-collar and
132 white-collar), and skill level of employment (37 unskilled, 29 partly skilled, 35 skilled
manual, 66 skilled non-manual, 31 managerial). The sample and methodology are also discussed
in a previous article [19].
Materials and Methods
Major Depression Inventory [MDI; 20; 21]. The MDI is comprised of 10 items, which
assess emotional and somatic symptoms of depression present in individuals during the past two
weeks. These items reflect the DSM-IV major depression criteria. Participants responded to
each item utilizing a six-point Likert scale, ranging from 0 (at no time) to 5 (all of the time).
Depression scores were calculated by summing the (mean = 7.76, SD = 7.82) participants’
responses on each item, with a potential range of 0 to 50. A MDI score of 26 is considered to be
the accepted clinical cut-off [22], and 11 participants in this study reported MDI scores above
such value. Cronbach’s alpha for the scores of the items on the MDI with this particular
population was 0.92.
Hopelessness Scale [7]. To assess hopelessness, two items were included in the survey:
“I feel that it is impossible to reach the goals I would like to strive for” and “The future seems to
me to be hopeless, and I can't believe that things are changing for the better.” Participants
responded to both items on a five-point Likert scale (0 = absolutely agree to 4 = absolutely
disagree). The two items were reverse scored and summed, so higher scores reflected greater
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levels of hopelessness (mean = 2.00, SD = 2.07). The correlation between the two items was
0.82. These items have been utilized to assess hopelessness in previous research [7, 23; 24].
Cortisol [cf. 19]. The samples were mailed to the laboratory, centrifuged, transferred to
1.5 ml Eppendorf tubes, and frozen at -20 ºC. A time-resolved fluorescence detection method
was used to determine cortisol [cf. 25]. Intra-assay coefficients were less than 10%.
Procedure
Before information and materials regarding saliva collection were mailed home to the
participants, the procedures and aims of the study were explained to potential participants and all
provided written consent. The instructions requested that participants collect saliva on three
consecutive working days that did not include Fridays, Mondays, or holidays (i.e., Tuesdays,
Wednesdays, and Thursdays) 30 minutes after awakening (prior to breakfast) and in the evening
(prior to sleeping). These time points were selected because diurnal cortisol deviation from
morning to evening is widely used [26], and a recent review found the most consistent
associations between depressive symptoms and saliva cortisol when diurnal cortisol deviation
was measured compared to other methods to measure saliva cortisol [e.g., single time point
measures; 27]. Thus, participants were instructed to collect saliva samples 30 minutes after
awakening (prior to breakfast) and in the evening (prior to sleeping). Participants were provided
Salivette collection devices to collect the saliva samples and instructed to freeze them
immediately after collection.
The time in which saliva samples are obtained can affect the evaluation of the cortisol
response [cf. 28; 29]. Thus, participants were instructed to complete a form detailing their
awakening and sampling time. The forms were all completed. Samples that were to be obtained
30 minutes after awakening were excluded if they were collected outside of a 10 minute grace
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period (i.e., 20 minutes or less, 40 minutes or more). Moreover, samples were excluded if the
participants did not adhere to the fasting instructions, cortisol responses were not able to be
determined due to insufficient amount of saliva or technical error, or the cortisol value was an
outlier (i.e., ±2 SDs from mean). Overall, 9, 11, and 16 samples were excluded from the first,
second, and third day, respectively.
Data Analysis
Mean values for both sampling times were calculated across the three consecutive days.
After the exclusion criteria were applied and mean values calculated, eight missing values were
reported for the 30 minutes after awakening sample and two missing values were reported for the
evening sample. Because the cortisol data were skewed, logarithmic transformation was used.
To calculate diurnal cortisol rhythm, the arithmetic difference between the logarithmic
transformed morning value (i.e., 30 minutes after awakening samples; mean = 1.49, SD = 0.18)
and the logarithmic evening value (mean = 0.63, SD = 0.22) was obtained.
Based on Preacher and Hayes’ [30] widely used approach to test for mediation, mediation
is characterized by an indirect relationship between a predictor variable and dependent variable
through a mediator. Thus, to test the hypothesis that depressive symptoms mediate the
association between hopelessness and diurnal cortisol rhythm, two linear regression analyses and
asymmetrical confidence intervals around the regressions weights were calculated using SPSS
21. One linear regression was conducted to examine whether hopelessness predicts depressive
symptoms while controlling for the effects of age, gender, awakening time, and medication use
on this association. A second linear regression analysis was conducted to examine whether
depressive symptoms predict diurnal cortisol rhythm, while controlling for the above mentioned
variables and for the effect of hopelessness. Finally, 95% confidence intervals for the regression
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weights were calculated using PRODCLIN [31]. The upper and lower confidence limits have
different critical values because PRODCLIN uses the product method, which follows an
asymmetrical distribution [31]. A statistically significant mediation effect exists when the
confidence limits do not contain zero. To evaluate an alternative model in which hopelessness
mediates the association between depressive symptoms and diurnal cortisol rhythm, a second set
of analyses was conducted. This set of analyses included (a) a linear regression analysis with
depressive symptoms predicting hopelessness while controlling for the effects of age, gender,
awakening time, and medication use on this association; (b) a linear regression analysis with
hopelessness predicting diurnal cortisol rhythm while controlling for the above mentioned
variables and depressive symptoms; (c) calculations of the confidence intervals around the
regression weights of the association of hopelessness with depressive symptoms and of
hopelessness with diurnal cortisol rhythm.
Results
Means and standard deviations for the variables and correlations between the variables
utilized in the study are reported in Table 1.
Depressive Symptoms as Mediator. As expected, after adjusting for age, gender,
awakening time, and medication use, more hopelessness predicted more depressive symptoms (p
< .001; Table 2). Moreover, there was a negative association between depressive symptoms and
diurnal cortisol rhythm (p < .01), after controlling for age, gender, awakening time, and
medication use. This association remained significant after including hopelessness as a control
variable as well (p < .05; Table 2). In other words, replicating previous findings, more
depressive symptoms predicted a flatter diurnal cortisol rhythm. An examination of the 95%
confidence intervals revealed that the indirect relationship between hopelenessness and diurnal
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cortisol rhythm did not include zero and was therefore significant (-.015, -.003). Thus, the
hypothesis that depressive symptoms mediate the assocation between hopelessness and diurnal
cortisol rhythm was supported.
Hopelessness as Mediator. As expected, after adjusting for age, gender, awakening time,
and medication use, more depressive symptoms predicted more hopelessness (p < .001; Table 3).
However, there was only a non-significant direct association between hopelessness and diurnal
cortisol rhythm (p = n.s.), after controlling for age, gender, awakening time, and medication use.
As to be expected, this association remained non-significant when controlling for depressive
symptoms as well (p = n.s.; Table 3). In addition, an examination of the 95% confidence
intervals revealed that the indirect relationship between depressive symptoms and diurnal
cortisol rhythm did include zero and was therefore not significant (-.003, .000). Thus,
hopelessness does not mediate the assocation between depressive symptoms and diurnal cortisol
rhythm.
Discussion
Based on theoretical considerations [6; 5] and empirical findings [e.g., 17; 18] the aim of
the study was to test the hypothesis that depressive symptoms mediate the association between
hopelessness and diurnal cortisol rhythm. Consistent with the prediction, hopelessness predicted
more depressive symptoms and more depressive symptoms predicted a flatter diurnal cortisol
rhythm. Further, depressive symptoms mediated the relationship between hopelenessness and
diurnal cortisol rhythm. Although contrary to previous literature, an alternative model
examining whether hopelessness mediated the association between depressive symptoms and
diurnal cortisol rhythm was also explored. Results revealed that depressive symptoms predicted
hopelessness while hopelessness was not directly associated with a flattened diurnal cortisol
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rhythm. Thus, hopelessness did not mediate the assocation between depressive symptoms and
diurnal cortisol rhythm. Summarized, the hypothesis that depressive symptoms mediate the
assocation between hopelessness and diurnal cortisol rhythm was supported. Additionally, there
was no support for the model of hopelessness mediating the association between depressive
symptoms and diurnal cortisol rhythm. This pattern of results even allows to conclude that
hopelessness is not directly but only through depressive symptoms associated with diurnal
cortisol rhythm.
A flattened diurnal cortisol rhythms has been proposed to be associated with a decreased
responsiveness of the immune system to cortisol mediated signaling. In other words, cortisol is
less able to suppress inflammatory control pathways which results in increased concentrations of
inflammatory biomarkers, such as IL-6 and CRP [32]. This hypothesis is supported by findings
of a recent meta-analysis [33]. In parallel, depressive symptoms and hopelessness have been
shown to be predictors of mean and maximum carotid artery IMT [8]. Because chronically
elevated inflammatory biomarkers and IMT are associated with increased risk for cancer and
CVD [34], future research should replicate the findings of this study and examine the
relationship between hopelessness, depressive symptoms, inflammatory biomarkers, and IMT,
cancer, and CVD.
Previous research has explored the effects of some factors associated with depression on
physical health outcomes, including childhood abuse [35], a negative attribution style [36], and
low self-esteem [37]; however, additional factors associated with depression still remain
unexplored. Considering that both Beck’s cognitive theory [5] and the hopelessness model [6]
propose multiple cognitive vulnerability factors associated with depression (i.e., dysfunctional
attitudes, cognitive errors, cognitive triad, negative automatic thoughts, pessimistic cognitive
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style), studies including multiple psychosocial factors seem fruitful, especially given the
interplay that exists between these factors [e.g., 38]. Further, Beck’s cognitive theory proposes
that hopelessness is only one part of the cognitive triad. The cognitive triad is a set of negative
cognitions focusing on the future (hopelessness), the self, and the world. As such, not only longrange projections, anticipating that current difficulties or suffering will continue indefinitely
(negative view of the future) but also attributions of negative events to personal psychological,
moral, or physical defect (negative view of the self) and the view that the world makes exorbitant
demands and/or presents insuperable obstacles to reach life goals (negative view of the world)
increase the risk to develop depressive symptoms [5]. Thus, it would be especially interesting to
study the associations between all three parts of the cognitive triad, depressive symptoms, and
physical health. Such studies will contribute to a further integration of psychological and
biological models into a bio-psycho-social model of heart health.
Limitations of this study should be considered while interpreting the findings. Self-report
measures were utilized to assess hopelessness and depressive symptoms, rather than structured
interviews. Additionally, the hopelessness scale lacks convergent and divergent validity;
however, it has produced valid scores and predicted cardiovascular and metabolic outcomes in
prior research [19, 39]. Further and probably most important is the cross-sectional design of the
study. This precludes drawing of causal conclusions. In addition, while hopelessness is not a
symptom in the DSM-5 [40], some researchers conceptualize hopelessness not as risk factor of
depression but as a symptom of depression [e.g., 41]. Thus, an alternative interpretation of our
findings is that hopelessness is simply the “active symptom” that impacts other depressive
symptoms which are associated with diurnal cortisol rhythm. To overcome the limitations of a
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cross-sectional study, a three wave longitudinal study with equal time lags between the waves is
needed [42].
Summarized, the present study supports the hypothesis that the relationship between
hopelessness and diurnal cortisol rhythm is mediated by depressive symptoms. However, based
on the present findings, asking for hopelessness does not substitute for screening of major
depressive disorder when investigating the impact of depression on diurnal cortisol rhythm. As
this study was cross-sectional and many other factors associated with depression have not been
examined, future research should explore the relationships between such factors, depressive
symptoms, and biological risk factors of cancer and CVD.
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Table 1
Means and Standard Deviations for and Correlations between Hopelessness, Depressive Symptoms,
Cortisol Rhythm, and Control Variables
Variable
1 Hopelessness

1

2

3

4

5

6

7

--

2 Depressive symptoms

.41***

3 Cortisol rhythm

-.15*

-.19**

4 Age

.11

-.06

-.10

--

5 Gender

.13*

.29***

-.01

-.01

--

6 Awakening time

-.09

.13*

.06

-.10

.23***

--

7 Medication use

.18**

.22***

.23***

.07

*p < .05; **p < .01; ***p < .001

---

-.10

.37***

--
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Table 2
Regression results with Hopelessness as Predictor of Depressive Symptoms (upper part) and Depressive
Symptoms and Hopelessness as Predictors of Diurnal Cortisol Rhythm (lower part) to test the Model of
Depressive Symptoms as Mediator between Hopelessness and Cortisol
Dependent Variable

Depressive Symptoms
Step 1
β

R2

Predictors
Age

Step 2
β

R2

-.13*

-.15*

Gender

.24***

.20***

Awakening time

.04

.08

Medication use

.20**

.15*

Hopelessness
2

.38***

R change

.13***

.14***

Total R2

.13

.27

Dependent Variable

Cortisol Rhythm
Step 1
β

R2

Predictors

Step 2

Step 3
β

R2

β

R2

Age

-.07

-.10

-.09

Gender

-.01

.04

.04

Awakening time

.06

.06

.06

Medication use

-.08

-.04

-.04

-.21**

-.19*

Depressive Symptoms
Hopelessness

.05

R2 change

.02

.04**

.00

Total R2

.02

.06

.06

Note. + p < .10; *p < .05; **p < .01; ***p < .001

Running head: Depressive Symptoms, Hopelessness, and Cortisol
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Table 3
Regression results with Depressive Symptoms as Predictor of Hopelessness (upper part) and Depressive
Symptoms and Hopelessness as Predictors of Diurnal Cortisol Rhythm (lower part) to test the Model of
Hopelessness as Mediator between Depressive Symptoms and Cortisol
Dependent Variable

Hopelessness
Step 1
β

R2

Predictors

Step 2
β

R2

Age

.04

.09

Gender

.13+

.03

Awakening time

-.13+

Medication use

β

R2

-.14*

.15*

.06

Depressive Symptoms
2

Step 3

.42***

R change

.06**

.15***

Total R2

.06

.21

Dependent Variable

Cortisol Rhythm
Step 1
β

R2

Predictors

Step 2

Step 3
β

R2

β

R2

Age

-.07

-.06

-.09

Gender

-.01

.01

.04

Awakening time

.06

.04

.06

Medication use

.08

-.06

-.04

-.13+

-.05

Hopelessness
Depressive Symptoms

-.19*

R2 change

.02

.02+

.03*

Total R2

.02

.03

.06

Note. + p < .10; *p < .05; **p < .01; ***p < .001

